首页>
外国专利>
adalimumab and its pharmaceutically acceptable derivatives (HUMIRA®)
adalimumab and its pharmaceutically acceptable derivatives (HUMIRA®)
展开▼
机译:阿达木单抗及其药学上可接受的衍生物(HUMIRA®)
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
展开▼